A Study to Assess the Safety and Tolerability of MPDL3280A in Combination With Other Immune-modulating Therapies in Patients With Locally Advanced or Metastatic Solid Tumors

Clinical Trial ID NCT02174172

Rank	Title	Journal	Year	PubWeight™‹?›
1	Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy.	Biomed Res Int	2015	1.25
2	Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications.	Oncoimmunology	2015	1.06
3	New strategies in immunotherapy for non-small cell lung cancer.	Transl Lung Cancer Res	2015	0.89
4	The past, present and future of immunotherapy against tumor.	Transl Lung Cancer Res	2015	0.85
5	Emerging therapeutic targets in metastatic progression: A focus on breast cancer.	Pharmacol Ther	2016	0.79
6	Antibody-based immunotherapy of solid cancers: progress and possibilities.	Immunotherapy	2015	0.77
7	Trial Watch-Immunostimulation with cytokines in cancer therapy.	Oncoimmunology	2015	0.77
8	Immunotherapy in non-small cell lung cancer: the clinical impact of immune response and targeting.	Ann Transl Med	2016	0.77
9	Adjuvant immunotherapy in resected early non-small cell lung cancer-battle lost, hopefully not the war!	J Thorac Dis	2016	0.75